Fund shareholders of Viridian Therapeutics Inc
ISIN US92790C1045 · United States · LEI 549300C775BNYF550E70
- Fund shareholders
- 263
- Of which ETFs
- 50 213 other funds
- Value held
- 766.8M $ 1.1M € · 29.2M SEK
- Share of capital
- 34.6 % of 113.3M shares on Aug 3, 2026
263 funds hold this company. This table lists the 262 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 5,600 | 109.5K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VY(R) JPMORGAN SMALL CAP CORE EQUITY PORTFOLIO Voya Investors Trust | 5,494 | 107.5K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares MSCI World Small-Cap ETF iShares Trust | 5,125 | 150.6K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 5,101 | 99.8K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 4,945 | 145.3K $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 4,927 | 144.8K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 4,821 | 65K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| AVIP BlackRock Advantage Small Cap Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 4,793 | 93.8K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 4,782 | 93.5K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 3,729 | 109.6K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 3,603 | 48.6K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 3,492 | 102.6K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 3,464 | 101.8K $ | 0.07 % | 0.00 % | as of Feb 28, 2026 ↗ |
| MetLife Small Company Equity Fund ADVISORS' INNER CIRCLE III | 3,430 | 67.1K $ | 0.95 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell Investments U.S. Small Cap Equity ETF Russell Investments Exchange Traded Funds | 3,135 | 61.3K $ | 0.12 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BNY Mellon US Small Cap Core Equity ETF BNY Mellon ETF Trust | 3,045 | 41K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 2,823 | 38.1K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 2,671 | 52.2K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 2,525 | 34K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| 1290 VT Small Cap Value Portfolio EQ Advisors Trust | 2,504 | 49K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 2,359 | 46.1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JPMorgan Healthcare Leaders ETF J.P. Morgan Exchange-Traded Fund Trust | 2,323 | 31.3K $ | 0.28 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 2,252 | 44K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 2,200 | 43K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 2,026 | 39.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,899 | 37.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,883 | 55.3K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 1,842 | 36K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Small Cap Stock K6 Fund Fidelity Concord Street Trust | 1,747 | 23.5K $ | 0.13 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 1,684 | 32.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,649 | 22.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,534 | 30K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Healthy Future Fund Fidelity Summer Street Trust | 1,510 | 20.4K $ | 0.14 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 1,494 | 29.2K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 1,200 | 16.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 1,100 | 21.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 1,050 | 20.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 932 | 27.4K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 917 | 12.4K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 728 | 14.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 699 | 13.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 609 | 11.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 571 | 7.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 479 | 6.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 473 | 9.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 397 | 7.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 394 | 7.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 312 | 6.1K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 272 | 5.3K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 206 | 4K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 182 | 3.6K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Sustainable U.S. Market Fund Fidelity Summer Street Trust | 169 | 2.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 148 | 2K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 117 | 1.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 109 | 2.1K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 86 | 1.7K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 86 | 1.2K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 82 | 2.4K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 25 | 734.5 $ | 0.07 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 21 | 410.8 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 4 | 117.5 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 1.1M € | 1.28 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Simplify Propel Opportunities ETF Simplify Exchange Traded Funds | 1.59 % | as of Mar 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 1.34 % | as of Feb 28, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 1.28 % | as of Dec 31, 2025 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 1.26 % | as of Apr 30, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 1.00 % | as of Mar 31, 2026 ↗ |
| MetLife Small Company Equity Fund ADVISORS' INNER CIRCLE III | 0.95 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 0.93 % | as of Feb 27, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 0.85 % | as of Sep 30, 2025 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.70 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.68 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 260 | +21 | 38,986,434 | +11.3 % |
| 2026Q1 | 239 | +37 | 35,035,987 | +20.3 % |
| 2025Q4 | 202 | +13 | 29,125,461 | +1.8 % |
| 2025Q3 | 189 | -1 | 28,614,323 | +0.8 % |
| 2025Q2 | 190 | +4 | 28,377,203 | +1.0 % |
| 2025Q1 | 186 | +15 | 28,109,149 | +20.5 % |
| 2024Q4 | 171 | +16 | 23,321,316 | +16.1 % |
| 2024Q3 | 155 | -10 | 20,083,708 | -10.5 % |
| 2024Q2 | 165 | +14 | 22,428,182 | +40.2 % |
| 2024Q1 | 151 | +20 | 15,997,040 | +63.2 % |
| 2023Q4 | 131 | 9,805,027 |
Institutional managers
217 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 15,379,377 | 300.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 7,831,475 | 153.2M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 6,726,144 | 131.6M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,672,885 | 91.4M $ | as of Mar 31, 2026 |
| Fairmount Funds Management LLC | 3,914,458 | 76.6M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 3,882,709 | 75.9M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,206,035 | 62.7K $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 3,148,893 | 61.6M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,078,554 | 60.2M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 2,341,652 | 45.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,333,213 | 45.6M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 2,318,234 | 45.3M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 2,315,957 | 45.3M $ | as of Mar 31, 2026 |
| NOVO HOLDINGS A/S | 2,000,000 | 39.1M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 1,971,678 | 38.6M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 1,792,626 | 35.1M $ | as of Mar 31, 2026 |
| Fisher Asset Management, LLC | 1,768,295 | 34.6M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,591,945 | 31.1M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 1,500,000 | 29.3M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 1,393,944 | 27.3M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 1,392,072 | 43.3M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,262,540 | 24.7M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 1,170,829 | 22.9M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,163,615 | 22.8M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 1,059,864 | 19.6M $ | as of Mar 31, 2026 |
Declared shareholders of Viridian Therapeutics Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Fairmount Funds Management LLC and 1 other | 14.04 % | 17,201,800 | as of May 11, 2026 · SCHEDULE 13D |
| Bellevue Group AG and 1 other | 6.60 % | 6,726,144 | as of Mar 31, 2026 · SCHEDULE 13G |
| Deep Track Capital, LP and 2 others | 5.30 % | 5,417,660 | as of May 1, 2026 · SCHEDULE 13G |
| Paradigm BioCapital Advisors LP and 3 others | 5.10 % | 5,633,788 | as of Jun 18, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Viridian Therapeutics Inc". https://titelia.com/en/stocks/viridian-therapeutics-inc-US92790C1045